Wikidata

(Q61918404)

English

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Randomized Phase III Trial of Neoadjuvant Therapy for Patients With Palpable and Operable HER2-Positive Breast Cancer Comparing the Combination of Trastuzumab Plus Lapatinib to Trastuzumab and to Lapatinib Administered With Weekly Paclitaxel Following AC Accompanied by Correlative Science Studies to Identify Predictors of Pathologic Complete Response (English)
0 references
country
Canada
0 references
start time
July 2007
0 references
end time
June 2012
0 references
number of participants
529
0 references
research intervention
paclitaxel
0 references
Caelyx
0 references
lapatinib
0 references
(RS)-cyclophosphamide
0 references
doxorubicin
0 references
trastuzumab
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61918404&oldid=2180458169"